Last days to vote for the big winner of the Euro Health Innovation Award
Published in: July 30, 2020
and updated in: November 4, 2021
Listen to the text
Stop the audio
Sao Paulo, July 2020 – Doctors interested in voting on their favorite for the overall winner of the Euro Health Innovation Award have only until August 4 to participate. Out of the more than 1,655 submitted projects, 11 innovative, socially-impactful health initiatives were selected. Of those, 10 have already been awarded the corresponding amount to fifty thousand euros (€50,000.00) in Brazilian reais each, and the big winner will receive the corresponding amount to five hundred thousand euros (€500,000.00) in Brazilian reais.
Doctors wishing to cast their votes for their favorite project must register at www.premioeuro.com.br, where all relevant information on the candidates are available for consultations. The result will come out in September.
Euro Innovation Award
The initiative, unprecedented in Brazil, was sponsored exclusively by Eurofarma, which saw the award as an opportunity to encourage health innovation, endorsing projects that can be implemented with effective results, in addition to reaffirming the company’s belief in supporting medical professionals throughout the country.
“We are very happy with the whole journey leading up to the choice of the big winner. The medical community really engaged in the project, exceeding our expectations. We found interesting initiatives that can make a difference in the health of Brazilians”, says Roberta Junqueira, Eurofarma’s Commercial Director.
The award will distribute a total amount of €1 million (equivalent in Brazilian reais, subject to income tax withholding).
About Eurofarma Group
As the first multinational pharmaceutical company with 100% Brazilian capital, the Eurofarma Group has been operating in the health industry since its establishment in 1972, producing and marketing innovative products and services to improve people’s quality of life. Focused on generating shared value, it operates in the areas of Prescription, Non-Prescription, and Generic Drugs, Hospital, Oncology and Veterinary. In Brazil alone, it offers 313 products, 649 dosage forms, serves 25 medical specialties and covers 89 therapeutic classes, which represent 81% of prescriptions in the brand market.
The Eurofarma Group has own operations in 20 countries, with an industrial park in Brazil and plants in 6 more Latin American countries. Reported sales totaled BRL 5.6 billion in 2019 and the Group employs over 7,000 employees.
Eurofarma in social media
Facebook: @eurofarma | LinkedIn: @eurofarma
Instagram: @eurofarmalab | Twitter: @eurofarmaLab
Doctors wishing to cast their votes for their favorite project must register at www.premioeuro.com.br, where all relevant information on the candidates are available for consultations. The result will come out in September.
Euro Innovation Award
The initiative, unprecedented in Brazil, was sponsored exclusively by Eurofarma, which saw the award as an opportunity to encourage health innovation, endorsing projects that can be implemented with effective results, in addition to reaffirming the company’s belief in supporting medical professionals throughout the country.
“We are very happy with the whole journey leading up to the choice of the big winner. The medical community really engaged in the project, exceeding our expectations. We found interesting initiatives that can make a difference in the health of Brazilians”, says Roberta Junqueira, Eurofarma’s Commercial Director.
The award will distribute a total amount of €1 million (equivalent in Brazilian reais, subject to income tax withholding).
About Eurofarma Group
As the first multinational pharmaceutical company with 100% Brazilian capital, the Eurofarma Group has been operating in the health industry since its establishment in 1972, producing and marketing innovative products and services to improve people’s quality of life. Focused on generating shared value, it operates in the areas of Prescription, Non-Prescription, and Generic Drugs, Hospital, Oncology and Veterinary. In Brazil alone, it offers 313 products, 649 dosage forms, serves 25 medical specialties and covers 89 therapeutic classes, which represent 81% of prescriptions in the brand market.
The Eurofarma Group has own operations in 20 countries, with an industrial park in Brazil and plants in 6 more Latin American countries. Reported sales totaled BRL 5.6 billion in 2019 and the Group employs over 7,000 employees.
Eurofarma in social media
Facebook: @eurofarma | LinkedIn: @eurofarma
Instagram: @eurofarmalab | Twitter: @eurofarmaLab